Report Detail

HPV infections can infect the genital areas of men including the skin on and around the penis or anus. These infections can also be spread to the mouth and the throat. According to CDC, about 1% of sexually active men in the U.S. have genital warts at any given time. Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, penile cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men. The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men. The selective product availability has restricted the growth of the market to a specific gender leading to slow growth over the forecast period.
In 2019, the market size of Molecular Human Papillomavirus (HPV) Diagnostic Equipment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Molecular Human Papillomavirus (HPV) Diagnostic Equipment.

This report studies the global market size of Molecular Human Papillomavirus (HPV) Diagnostic Equipment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Molecular Human Papillomavirus (HPV) Diagnostic Equipment production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Becton, Dickinson and Company
Qiagen N.V.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Hologic Inc.
Cepheid Inc.
Seegene Inc.
Takara Bio Inc.
DaAn Gene Co., Ltd. of Sun Yat-Sen University
Promega Corporation
Greiner Bio-One International GmbH (Greiner Holding AG)
Enzo Biochem Inc.
Norgen Biotek Corp.
DiagCor Bioscience Inc Ltd
Hybribio Limited
Zytovision GmbH
Arbor Vita Corporation
Medical & Biological Laboratories Co., Ltd
Fujirebio Diagnostics, Inc.

Market Segment by Product Type
Services
Assay kits
System

Market Segment by Application
Hosptial
Clinic

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Molecular Human Papillomavirus (HPV) Diagnostic Equipment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Molecular Human Papillomavirus (HPV) Diagnostic Equipment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Molecular Human Papillomavirus (HPV) Diagnostic Equipment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Services
      • 1.3.3 Assay kits
      • 1.3.4 System
    • 1.4 Market Segment by Application
      • 1.4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share by Application (2019-2025)
      • 1.4.2 Hosptial
      • 1.4.3 Clinic
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value 2014-2025
      • 2.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production 2014-2025
      • 2.1.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity 2014-2025
      • 2.1.4 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size CAGR of Key Regions
      • 2.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity by Manufacturers
      • 3.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Price by Manufacturers
    • 3.4 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market
    • 3.6 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Services Production and Production Value (2014-2019)
      • 4.1.2 Assay kits Production and Production Value (2014-2019)
      • 4.1.3 System Production and Production Value (2014-2019)
    • 4.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Market Share by Type
    • 4.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Market Share by Type
    • 4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application

    6 Production by Regions

    • 6.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production (History Data) by Regions 2014-2019
    • 6.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2014-2019
      • 6.3.2 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2014-2019
      • 6.4.2 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
    • 6.5 China
      • 6.5.1 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2014-2019
      • 6.5.2 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Regions

    • 7.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
      • 7.2.2 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
      • 7.3.2 European Union Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
    • 7.4 China
      • 7.4.1 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
      • 7.4.2 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
      • 7.5.2 Rest of World Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 F. Hoffmann-La Roche Ltd.
      • 8.1.1 F. Hoffmann-La Roche Ltd. Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.1.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.1.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 8.2 Agilent Technologies, Inc.
      • 8.2.1 Agilent Technologies, Inc. Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.2.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.2.5 Agilent Technologies, Inc. Recent Development
    • 8.3 Becton, Dickinson and Company
      • 8.3.1 Becton, Dickinson and Company Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.3.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.3.5 Becton, Dickinson and Company Recent Development
    • 8.4 Qiagen N.V.
      • 8.4.1 Qiagen N.V. Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.4.5 Qiagen N.V. Recent Development
    • 8.5 Thermo Fisher Scientific Inc.
      • 8.5.1 Thermo Fisher Scientific Inc. Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.5.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.5.5 Thermo Fisher Scientific Inc. Recent Development
    • 8.6 Abbott Laboratories
      • 8.6.1 Abbott Laboratories Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.6.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.6.5 Abbott Laboratories Recent Development
    • 8.7 Hologic Inc.
      • 8.7.1 Hologic Inc. Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.7.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.7.5 Hologic Inc. Recent Development
    • 8.8 Cepheid Inc.
      • 8.8.1 Cepheid Inc. Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.8.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.8.5 Cepheid Inc. Recent Development
    • 8.9 Seegene Inc.
      • 8.9.1 Seegene Inc. Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.9.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.9.5 Seegene Inc. Recent Development
    • 8.10 Takara Bio Inc.
      • 8.10.1 Takara Bio Inc. Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
      • 8.10.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
      • 8.10.5 Takara Bio Inc. Recent Development
    • 8.11 DaAn Gene Co., Ltd. of Sun Yat-Sen University
    • 8.12 Promega Corporation
    • 8.13 Greiner Bio-One International GmbH (Greiner Holding AG)
    • 8.14 Enzo Biochem Inc.
    • 8.15 Norgen Biotek Corp.
    • 8.16 DiagCor Bioscience Inc Ltd
    • 8.17 Hybribio Limited
    • 8.18 Zytovision GmbH
    • 8.19 Arbor Vita Corporation
    • 8.20 Medical & Biological Laboratories Co., Ltd
    • 8.21 Fujirebio Diagnostics, Inc.

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Forecast by Type
      • 9.7.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales Channels
      • 10.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Distributors
    • 10.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Molecular Human Papillomavirus (HPV) Diagnostic Equipment. Industry analysis & Market Report on Molecular Human Papillomavirus (HPV) Diagnostic Equipment is a syndicated market report, published as Global (United States, European Union and China) Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Molecular Human Papillomavirus (HPV) Diagnostic Equipment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,578.08
      3,867.12
      5,156.16
      3,099.60
      4,649.40
      6,199.20
      509,056.00
      763,584.00
      1,018,112.00
      276,963.20
      415,444.80
      553,926.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report